Ao Z, Ouyang MJ, Olukitibi TA, Warner B, et al. A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection. J Virol 2022 Sep 7:e0133722. doi: 10.1128/jvi.01337.
PMID: 36069551